Erratum: Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids (Nature Communications (2013) 4 (1867) DOI:10.1038/ncomms2886);Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids

Nature Communications

Volumn 4, Issue , 2013, Pages

  Wang, Qilong ^a,b   Zhuang, Xiaoying ^b   Mu, Jingyao ^b   Deng, Zhong Bin ^b   Jiang, Hong ^a,b   Xiang, Xiaoyu ^b   Wang, Baomei ^b   Yan, Jun ^b   Miller, Donald ^b   Zhang, Huang Ge ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DNA; FOLATE RECEPTOR; FOLIC ACID; LIPID; NANOPARTICLE; SMALL INTERFERING RNA;

CHEMOTHERAPY; CYTOLOGY; FRUIT; GENE EXPRESSION; INHIBITION; LIPID; NANOTECHNOLOGY; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PLACENTA BARRIER; CANCER INHIBITION; CELL TYPE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXPERIMENTAL MODEL; FEMALE; GRAPEFRUIT; MOUSE; NONHUMAN;

ANIMALIA; CITRUS X PARADISI; MUS;

EID: 84878721096     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3358     Document Type: Erratum

References (36)

1. Sheth, P. et al. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production. Curr. Drug Deliv. 9, 269-284 (2012)
2. Sharma, A., Madhunapantula, S. V. & Robertson, G. P. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert. Opin. Drug Metab. Toxicol. 8, 47-69 (2012)
3. Chidambaram, M., Manavalan, R. & Kathiresan, K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J. Pharm. Pharm. Sci. 14, 67-77 (2011)
4. Yoo, J. W., Chambers, E. & Mitragotri, S. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr. Pharm. Des. 16, 2298-2307 (2010)
5. Thery, C., Ostrowski, M. & Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593 (2009)
6. Zoller, M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat. Rev. Cancer 9, 40-55 (2009)
7. Zhuang, X. et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19, 1769-1779 (2011)
8. Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341-345 (2011)
9. Tan, A., Rajadas, J. & Seifalian, A. M. Exosomes as nano-theranostic delivery platforms for gene therapy. Adv. Drug Deliv. Rev. 65, 357-367 (2012)
10. Sun, D. et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv. Drug Deliv. Rev. 65, 342-347 (2012)
11. Xiang, X. et al. TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes. Am. J. Pathol. 177, 1606-1610 (2010)
12. Yamashita, K. et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat. Nanotechnol. 6, 321-328 (2011)
13. Sood, A. et al. Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. Nat. Nanotechnol. 6, 824-833 (2011)
14. Haugland, R. P. & You, W. W. Coupling of monoclonal antibodies with biotin. Methods Mol. Biol. 45, 223-233 (1995)
15. Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001) (Pubitemid 32494397)
16. Leamon, C. P. & Jackman, A. L. Exploitation of the folate receptor in the management of cancer and inflammatory disease. Vitam. Horm. 79, 203-233 (2008)
17. Wang, S. & Low, P. S. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J. Control Release 53, 39-48 (1998) (Pubitemid 28218688)
18. Leamon, C. P. & Reddy, J. A. Folate-targeted chemotherapy. Adv. Drug Deliv. Rev. 56, 1127-1141 (2004) (Pubitemid 38496512)
19. Benns, J. M., Mahato, R. I. & Kim, S. W. Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft- polyethylenimine. J. Control Release 79, 255-269 (2002) (Pubitemid 34164178)
20. Nguyen, T. T. et al. Human intestinal folate transport: cloning, expression, and distribution of complementary RNA. Gastroenterology 112, 783-791 (1997) (Pubitemid 27113804)
21. Shih, Y. H., Zhuang, C. M., Peng, Y. H., Lin, C. H. & Tseng, Y. M. The effect of inorganic ions on the aggregation kinetics of lab-made TiO(2) nanoparticles in water. Sci. Total Environ. 435-436, 446-452 (2012)
22. Tsuji, J. S. et al. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol. Sci. 89, 42-50 (2006) (Pubitemid 43013753)
23. Xia, W. et al. Sensitive bioassay for detection of PPARalpha potentially hazardous ligands with gold nanoparticle probe. J. Hazard Mater. 192, 1148-1154 (2011)
24. Sayes, C. M., Reed, K. L. & Warheit, D. B. Nanoparticle toxicology: measurements of pulmonary hazard effects following exposures to nanoparticles. Methods Mol. Biol. 726, 313-324 (2011)
25. Mayer, A. et al. The role of nanoparticle size in hemocompatibility. Toxicology 258, 139-147 (2009)
26. Dreaden, E. C., Austin, L. A., Mackey, M. A. & El-Sayed, M. A. Size matters: gold nanoparticles in targeted cancer drug delivery. Ther. Deliv. 3, 457-478 (2012)
27. Qi, J., Lu, Y. & Wu, W. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles. Curr. Drug Metab. 13, 418-428 (2012)
28. Moghimi, S. M., Hunter, A. C. & Andresen, T. L. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu. Rev. Pharmacol. Toxicol. 52, 481-503 (2012)
29. Saha, R. N., Vasanthakumar, S., Bende, G. & Snehalatha, M. Nanoparticulate drug delivery systems for cancer chemotherapy. Mol. Membr. Biol. 27, 215-231 (2010)
30. Kwon, I. K., Lee, S. C., Han, B. & Park, K. Analysis on the current status of targeted drug delivery to tumors. J. Control Release 164, 108-114 (2012)
31. Hirsjarvi, S., Passirani, C. & Benoit, J. P. Passive and active tumour targeting with nanocarriers. Curr. Drug Discov. Technol. 8, 188-196 (2011)
32. Spilman, M. S., Welbon, C., Nelson, E. & Dokland, T. Cryo-electron tomography of porcine reproductive and respiratory syndrome virus: organization of the nucleocapsid. J. Gen. Virol. 90, 527-535 (2009)
33. Torrelles, J. B. et al. Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells. Glycobiology 22, 1118-1127 (2012)
34. Liu, Y. et al. Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am. J. Pathol. 176, 2490-2499 (2010)
35. Xiao, S. et al. Overexpression of Arabidopsis acyl-CoA binding protein ACBP3 promotes starvation-induced and age-dependent leaf senescence. Plant Cell 22, 1463-1482 (2010)
36. Wang, G. J. et al. Thymus exosomes-like particles induce regulatory T cells. J. Immunol. 181, 5242-5248 (2008).